T/R ratio for estimation of sample size in BE study of NTI drugs [Power / Sample Size]

posted by ElMaestro  – Denmark, 2017-10-25 14:34 (3143 d 15:48 ago) – Posting: # 17920
Views: 9,343

Hi Hötzi,

❝ Both are fine. Note that the FDA requires tighter batch release spec’s for NTIDs. Hence, in function sampleN.NTID() of PowerTOST the default is 0.975 – contrary to the usual 0.95.


This strays away from the usually stringent scientific principles that this forum usually promotes, doesn't it?
We plug in the GMR that we think/predict/guess is a realistic and relevant indicator of relative product performance, possibly with a buffer to factor in worst cases. Habits, experience and gut feeling.
There is no divine aspect of NTID's, as far as I know, that makes them easier to copy than non-NTID's from a strict formulation perspective so I don't know if the default is much science based.
Although I am sure 0.975 is condoned by the guy in the Armani suit.:-D He would definitely also like it for non-NTID's.

Perhaps all this boils down to the use of anything "default" in a power calculation. It is extremely handy. And it is a bit dangerous. Perhaps the world would be a better place altogether if such functions did not assume defaults for CV and GMR and designs - this would force users to actually *** badum tssss *** think just a little bit about the values they plug in before deriving a power.

OK, rant over, I'll take my medicine now. Stage III syphilis...

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
490 visitors (0 registered, 490 guests [including 19 identified bots]).
Forum time: 06:23 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5